Simultaneous analytical method [Bioanalytics]

posted by Obinoscopy  – USA, 2018-09-12 09:35 (738 d 08:25 ago) – Posting: # 19268
Views: 2,420

Dear Giang

» It's a bioanalytical method for determination of 5 anti-TB drugs by LC-MS/MS. One just raise the question: Can we apply this method for just 2/3 APIs? Is there any infuence or differences? Do we need to revalidate the method, partial or full, and which criteria? Many thanks!

I don't think you need to revalidate as long as the 2/3 APIs were among the 5 APIs that were validated.

But if I may ask, did you include all the CCs and QCs for the entire 5 APIs in the same analytical run?

Scopy

Complete thread:

Activity
 Admin contact
21,068 posts in 4,392 threads, 1,465 registered users;
online 14 (0 registered, 14 guests [including 11 identified bots]).
Forum time: Saturday 18:00 CEST (Europe/Vienna)

The purpose of models is not to fit the data,
but to sharpen the questions.    Samuel Karlin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5